logo

For the Inventor, By the Inventor

Suita, Japan

Makoto Iwane

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1995-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Makoto Iwane. Retrieved from https://idiyas.com/inventor/makoto-iwane

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 28(Granted Patents)


Location History:

  • Brookline, MA (US) (1997)
  • Suita, JP (1995 - 1999)

Company Filing History:

goldMedal4 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents

Years Active: 1995-1999

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents
1. 5981197 - Monoclonal antibody, hybridoma, their production and use thereof (1999-11-09),
2. 5858779 - Monoclonal antibody, hybridoma, their production and use thereof (1999-01-12),
3. 5639664 - Method for producing human nerve growth factor 2 (1997-06-17),
4. 5478740 - Hybridomas and monoclonal antibodies which specifically bind human basic (1995-12-26),

Title: The Innovations of Makoto Iwane

Introduction

Makoto Iwane is a prominent inventor based in Suita, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 4 patents to his name, Iwane's work has had a substantial impact on medical research and applications.

Latest Patents

One of Iwane's latest patents focuses on the production and use of monoclonal antibodies derived from cloned hybridomas. This innovative approach allows for the specific combination of the monoclonal antibody with basic fibroblast growth factor (bFGF). The implications of this patent are profound, as the monoclonal antibody can be utilized as assay reagents for bFGF or for its purification, enhancing research capabilities in the field.

Career Highlights

Iwane is currently associated with Takeda Chemical Industries, Inc., a leading company in the pharmaceutical sector. His work at Takeda has allowed him to further his research and development efforts, contributing to advancements in therapeutic solutions.

Collaborations

Throughout his career, Iwane has collaborated with notable colleagues such as Koichi Igarashi and Tsutomu Kurokawa. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Makoto Iwane's contributions to the field of biotechnology through his patents and collaborations highlight his role as a key innovator. His work continues to influence the development of important medical technologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…